Skip to main content

ADVERTISEMENT

Ankur Patel, MS

Original Contribution
06/03/2021
The aim of the study was to evaluate the safety and short-term efficacy of the Ranger paclitaxel-coated balloon (PCB; Boston Scientific) in the setting of CLI. 
The aim of the study was to evaluate the safety and short-term efficacy of the Ranger paclitaxel-coated balloon (PCB; Boston Scientific) in the setting of CLI. 
The aim of the study was to...
06/03/2021
Original Research
08/04/2020
The objective of this study is to estimate health care spending among patients with Stage 3 and Stage 4 pressure injuries and patients with diabetic foot ulcers who experienced early (ie, within 30 days of index diagnosis) versus late (31 to...
The objective of this study is to estimate health care spending among patients with Stage 3 and Stage 4 pressure injuries and patients with diabetic foot ulcers who experienced early (ie, within 30 days of index diagnosis) versus late (31 to...
The objective of this study is...
08/04/2020
Wounds
Purpose/Aim: Diabetic foot ulcers (DFU) have been estimated to affect 1–4% of patients with diabetes annually and a quarter of patients with diabetes over their lifetimes. Skin substitute...
11/23/2020
Introduction: Evidence for single-use Negative Pressure Wound Therapy (sNPWT) in managing surgical incisions is demonstrated across chronic and surgical indications. However, there is lim...
11/23/2020
Abstract Body: Introduction: Evidence for single-use Negative Pressure Wound Therapy (sNPWT) in managing surgical incisions is demonstrated across surgical indications. However, there is ...
11/23/2020
Introduction: Evidence for single-use negative pressure wound therapy (sNPWT) in managing surgical incisions is demonstrated across surgical indications. However, there is limited evidenc...
11/27/2019
Introduction: CCO is the only FDA approved enzymatic agent indicated for debriding chronic dermal ulcers. Purpose: The objective of this study was to estimate healthcare resource ut...
07/29/2019